The concentration of zinc has been shown to be altered in an extensive number of disorders of the central nervous system, including Alzheimer-type dementia, Down's syndrome, epilepsy, Friedreich's ataxia, multiple sclerosis, Parkinson's disease, schizophrenia, and alcoholism. The role of zinc metallothionein and other low-molecular-weight zinc-binding proteins in these conditions is currently being defined. Since several of these disorders are associated with oxidative stress, and since metallothionein is able to prevent the generation of free radicals, it is believed that cytokine-induced induction of metallothionein provides a long-lasting protection to avert oxidative damage. These topics are extensively discussed in the articles in this volume. Neuroanatomists, neurobiologists, neurochemists, neuropharmacologists, neurologists and psychiatrists will find this state-of-the-art publication a valuable addition to their libraries.
FREE Two-Day Shipping for students on millions of items. Learn more |
Book Description
Product Details
Would you like to update product info or give feedback on images?
|
Customer Reviews
|
There are no customer reviews yet.
|
|||
|
Video reviews
|
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
